Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients

BACKGROUND: This real-life study aimed to assess omalizumab treatment patterns in adult and paediatric asthma patients, and to describe asthma control and healthcare resource use (HCRU) at omalizumab initiation and discontinuation. METHODS: The French healthcare database system (Système National des...

Descripción completa

Detalles Bibliográficos
Autores principales: Humbert, Marc, Bourdin, Arnaud, Taillé, Camille, Kamar, Driss, Thonnelier, Céline, Lajoinie, Audrey, Rigault, Alexandre, Deschildre, Antoine, Molimard, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647070/
https://www.ncbi.nlm.nih.gov/pubmed/35618272
http://dx.doi.org/10.1183/13993003.03130-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647070/
https://www.ncbi.nlm.nih.gov/pubmed/35618272
http://dx.doi.org/10.1183/13993003.03130-2021

Ejemplares similares